Mark Kozloff to Bridged Bicyclo Compounds, Heterocyclic
This is a "connection" page, showing publications Mark Kozloff has written about Bridged Bicyclo Compounds, Heterocyclic.
Connection Strength
0.087
-
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440). Haematologica. 2021 11 01; 106(11):2834-2844.
Score: 0.048
-
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study. Ann Oncol. 2018 09 01; 29(9):1932-1938.
Score: 0.039